The Oligonucleotide & Precision Therapeutics (OPT) Congress will gather leading drug developers and discovery scientists to discuss technological and scientific advances in oligonucleotide-based therapeutics.

Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.

Check out this digital event at the OPT Congress